These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31238897)

  • 1. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
    Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
    BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.
    Skaga E; Kulesskiy E; Brynjulvsen M; Sandberg CJ; Potdar S; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
    Clin Transl Med; 2019 Dec; 8(1):33. PubMed ID: 31889236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
    Skaga E; Skaga IØ; Grieg Z; Sandberg CJ; Langmoen IA; Vik-Mo EO
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1495-1507. PubMed ID: 31028540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
    Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
    J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
    Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
    Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
    Daher A; de Groot J
    Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
    Hothi P; Martins TJ; Chen L; Deleyrolle L; Yoon JG; Reynolds B; Foltz G
    Oncotarget; 2012 Oct; 3(10):1124-36. PubMed ID: 23165409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data.
    Cheng HW; Liang YH; Kuo YL; Chuu CP; Lin CY; Lee MH; Wu AT; Yeh CT; Chen EI; Whang-Peng J; Su CL; Huang CY
    Cell Death Dis; 2015 May; 6(5):e1753. PubMed ID: 25950483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target.
    Renoult O; Laurent-Blond M; Awada H; Oliver L; Joalland N; Croyal M; Paris F; Gratas C; Pecqueur C
    Neuro Oncol; 2024 Sep; 26(9):1572-1586. PubMed ID: 38869884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
    Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
    Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.
    Yu KK; Taylor JT; Pathmanaban ON; Youshani AS; Beyit D; Dutko-Gwozdz J; Benson R; Griffiths G; Peers I; Cueppens P; Telfer BA; Williams KJ; McBain C; Kamaly-Asl ID; Bigger BW
    PLoS One; 2018; 13(3):e0193694. PubMed ID: 29499065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro demonstration of salinomycin as a novel chemotherapeutic agent for the treatment of SOX2‑positive glioblastoma cancer stem cells.
    Magrath JW; Raney WR; Kim Y
    Oncol Rep; 2020 Aug; 44(2):777-785. PubMed ID: 32627023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
    Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
    Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in silico screen links gene expression signatures to drug response in glioblastoma stem cells.
    Riddick G; Song H; Holbeck SL; Kopp W; Walling J; Ahn S; Zhang W; Fine HA
    Pharmacogenomics J; 2015 Aug; 15(4):347-53. PubMed ID: 25446780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
    Reddy RG; Bhat UA; Chakravarty S; Kumar A
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.